Section of Nephrology and Hypertension, Louisiana State University Health Science Center, New Orleans, LA, USA.
Curr Hypertens Rep. 2024 Jun;26(6):237-245. doi: 10.1007/s11906-024-01295-3. Epub 2024 Jan 25.
Our review explores the epidemiology, physiology, and clinical data surrounding the connection between hyperuricemia and metabolic syndrome, chronic kidney disease, and hypertension.
Compelling physiologic mechanisms have been proposed to explain a causal relationship between hyperuricemia and metabolic syndrome, chronic kidney disease, and hypertension but clinical studies have given mixed results in terms of whether intervening with hyperuricemia using urate-lowering therapy has any beneficial effects for patients with these conditions. Despite the large amount of research already put into this topic, more randomized placebo-controlled trials are needed to more firmly establish whether a cause-effect relationship exists and whether lowering uric acid levels in patients with these conditions is beneficial.
本综述探讨了高尿酸血症与代谢综合征、慢性肾脏病和高血压之间关联的流行病学、生理学和临床数据。
已经提出了一些有说服力的生理机制来解释高尿酸血症与代谢综合征、慢性肾脏病和高血压之间的因果关系,但在使用尿酸降低疗法干预高尿酸血症是否对这些疾病患者有任何有益影响方面,临床研究结果不一。尽管已经对这一课题进行了大量研究,但仍需要更多的随机安慰剂对照试验来更确定地确定是否存在因果关系,以及降低这些疾病患者的尿酸水平是否有益。